Innate Pharma Releases Its 2025 Financial Calendar

BusinesswireNov 20 14:00

Innate Pharma's IPH6501: A Promising Cancer Therapy

TipRanksNov 19 19:31

Innate Pharma Announces Publication in Science Immunology Highlighting Innovative Next-generation ANKET IPH6501

BusinesswireNov 19 14:00

Analysts Conflicted on These Healthcare Names: Alcon (ALC), Innate Pharma SA (OtherIPHYF) and ScPharmaceuticals (SCPH)

TipRanksNov 15 09:40 · Ratings

Evercore Maintains Innate Pharma(IPHA.US) With Buy Rating, Maintains Target Price $5

Futu NewsNov 14 21:31 · Ratings

Innate Pharma S.A. (IPHA) Q3 2024 Earnings Call Transcript Summary

Futu NewsNov 14 02:12 · Conference Call